Largest market shown
Germany
$142.7B calculated opportunity across 55 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Europe regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$142.7B calculated opportunity across 55 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $142.7B | 55 | Not reported | 7,785 km | 8 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| United KingdomGBR | $102.7B | 27 | Not reported | 8,151 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| Switzerland, LiechtensteinCHE | $95.9B | 17 | Reported | 8,084 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| NetherlandsNLD | $93.1B | 25 | Not reported | 7,831 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| BelgiumBEL | $84.3B | 20 | Not reported | 7,971 km | 5 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| FranceFRA | $75.2B | 28 | Not reported | 8,225 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| ItalyITA | $47.5B | 19 | Not reported | 8,135 km | 11 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts |
| PolandPOL | $41.0B | 21 | Not reported | 6,948 km | 37 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| SloveniaSVN | $40.5B | 8 | Not reported | 7,723 km | 8 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| SpainESP | $27.1B | 17 | Not reported | 9,232 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| IrelandIRL | $21.1B | 8 | Not reported | 8,291 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| SwedenSWE | $13.7B | 6 | Not reported | 6,714 km | 8 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| AustriaAUT | $12.8B | 8 | Not reported | 7,468 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| GreeceGRC | $11.1B | 4 | Not reported | 7,623 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| HungaryHUN | $11.1B | 5 | Not reported | 7,347 km | 7 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| DenmarkDNK | $10.3B | 5 | Not reported | 7,208 km | 4 | Vehicles: with only electric motor for propulsion |
| RussiaRUS | $9.8B | 4 | Not reported | 5,795 km | 10 | Turbines: parts of turbo-jets and turbo-propellers |
| FinlandFIN | $6.9B | 3 | Not reported | 6,327 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| NorwayNOR | $6.8B | 4 | Not reported | 7,031 km | 4 | Vehicles: with only electric motor for propulsion |
| CzechiaCZE | $6.4B | 4 | Not reported | 7,462 km | 25 | Product not reported |
| RomaniaROU | $3.7B | 2 | Not reported | 0 km | 0 | Vehicles: parts, gear boxes |
| SlovakiaSVK | $2.8B | 2 | Not reported | 7,422 km | 22 | Telephones for cellular networks or for other wireless networks |
| UkraineUKR | $1.4B | 1 | Not reported | 6,461 km | 7 | Product not reported |
| PortugalPRT | $1.2B | 1 | Not reported | 9,676 km | 7 | Heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives |
| CroatiaHRV | $1.0B | 1 | Not reported | 7,649 km | 20 | Product not reported |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $26.2B | +15.3% | +0.0% |
| 3 | BelgiumBEL | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $20.7B | +7.6% | +0.0% |
| 4 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 5 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 6 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $16.9B | +12.8% | +0.3% |
| 7 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 8 | United KingdomGBR | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 9 | BelgiumBEL | HS 271019Product description unavailable | $12.5B | +9.1% | +1.6% |
| 10 | GermanyDEU | HS 271019Product description unavailable | $12.1B | +5.8% | +0.9% |
| 11 | ItalyITA | HS 293719Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $11.7B | +29.0% | +0.2% |
| 12 | NetherlandsNLD | HS 271019Product description unavailable | $10.9B | +12.2% | +2.9% |
| 13 | PolandPOL | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $9.9B | +8.1% | +0.0% |
| 14 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.5% |
| 15 | SloveniaSVN | HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $8.5B | +30.0% | +11.9% |
| 16 | SloveniaSVN | HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $8.5B | +34.8% | +18.6% |
| 17 | BelgiumBEL | HS 300220Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
| 18 | Switzerland, LiechtensteinCHE | HS 740200Copper: unrefined, copper anodes for electrolytic refining | $7.4B | +25.1% | +0.0% |
| 19 | BelgiumBEL | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.1% |
| 20 | NetherlandsNLD | HS 870380Vehicles: with only electric motor for propulsion | $6.8B | +32.0% | +3.8% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 30
51 screened products with $335.7B of reported buyer imports.
$170.5BCalculated opportunity · +13.5% average growthHS2 87
67 screened products with $295.4B of reported buyer imports.
$132.2BCalculated opportunity · +20.9% average growthHS2 27
21 screened products with $222.4B of reported buyer imports.
$129.5BCalculated opportunity · +11.4% average growthHS2 00
29 screened products with $215.6B of reported buyer imports.
$93.6BCalculated opportunity · +8.5% average growthHS2 71
14 screened products with $227.2B of reported buyer imports.
$86.5BCalculated opportunity · +12.1% average growthHS2 29
17 screened products with $58.4B of reported buyer imports.
$62.1BCalculated opportunity · +23.7% average growthHS2 84
19 screened products with $75.2B of reported buyer imports.
$44.6BCalculated opportunity · +11.4% average growthHS2 88
10 screened products with $60.3B of reported buyer imports.
$33.0BCalculated opportunity · +9.5% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.